Genoptix (GXDX) Showing 30% to 40% Growth On The Top Line Year Over Year, According To Medical Devices Expert
Genoptix (GXDX) Showing 30% to 40% Growth On The Top Line Year Over Year, According To Medical Devices Expert
67 WALL STREET, New York – April 22, 2010 – The Wall Street Transcript has just published its Medical Devices Report offering a timely review of the sector to serious investors and industry executives. This Special feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952 …
Read more on Wall Street Transcript via Yahoo! Finance
Austria: No advance help for Greece News from the Lynch/van Otterloo YMCA: April 23 online edition